
About Lanark Laboratories Pvt Ltd
Data last updated:
Lanark Laboratories Pvt Ltd is a private limited company based in New Delhi, Delhi, India. It operates in the drug formulation and development segment of the pharmaceuticals sector. It was incorporated on 13 May 2001 and has been in existence for over 25 years.
The company is registered with the Registrar of Companies (ROC), Delhi, under CIN U24232DL2001PTC111048. Its GSTIN is 06AAACL8015D1ZY (Haryana).
The company has an authorised share capital of ₹2 Lakh and a paid-up capital of ₹2 Lakh. It is led by directors including Anil Mehta and Rajeev Mukul.
Its last annual general meeting (AGM) was held on 28 September 2024, and its latest financial statements are for the year ended 31 March 2024. The registered office is at 913, D – Mall Plot No. A – 1 Netaji Subhash Place Pitampura, New Delhi, Delhi, India – 110038.
As per the financials filed for FY 2024, the company reported a revenue of ₹4.56 Cr, a decline of 21% compared to the previous year. For the same year it recorded a net loss of ₹45.15 Lakh (net margin -9.9%) and EBITDA of -₹44.49 Lakh (EBITDA margin -9.8%). Revenue has grown at a compounded annual rate (CAGR) of 12% over three years and 46% over five years.
The company has about 18 employees on its provident fund (EPFO) records.
Court records list 2 cases involving the company, including 2 filed against it; 1 case is pending.
The current compliance status is marked as compliant by the Registrar of Companies. For more details, the company can be reached via its website lanarklab.com.
Company details
Contact details
Lanark Laboratories Pvt Ltd's registered office is in New Delhi, Delhi. Its website is lanarklab.com. Its e-mail address is in the company report.
- Email
- Website
- Registered Address913, D – Mall Plot No. A – 1 Netaji Subhash Place Pitampura, New Delhi, Delhi, India – 110038
- IndustryPharma, Drug Formulation & Development
To see the full contact details of Lanark Laboratories Pvt Ltd, buy the company report.
- Company details, directors and signatories
- Historical financials and ratios
- Shareholding pattern and group structure
- Charges with holder and property details
- Legal cases, compliance and MCA filings
Business activity
The main business activity of Lanark Laboratories is manufacturing. In detail, this covers chemical and chemical products, pharmaceuticals, medicinal chemical and botanical products.
| Main activity group code | Main activity | Business activity code | Business activity | Share of turnover |
|---|---|---|---|---|
| C | Manufacturing | C6 | Chemical and chemical products, pharmaceuticals, medicinal chemical and botanical products |
To see the full business activity and turnover split of Lanark Laboratories Pvt Ltd, buy the company report.
Financials of Lanark Laboratories Pvt Ltd
FY 2024 filings availableLanark Laboratories Pvt Ltd reported revenue of ₹4.56 Cr (down 21% YoY) for FY 2024.
Compounded Annual Growth Rate (CAGR)
Revenue fell 21% in the latest year, but over five years it has grown at a compounded annual rate (CAGR) of 46%. EBITDA fell 185% in the latest year. Three- and five-year figures are compounded annual growth rates (CAGR): the steady yearly rate that links the first and the last year. All are worked out from the filed statements.
Financial Statement Summary
| Metrics | FY 2023-24 | FY 2022-23 | FY 2021-22 | FY 2020-21 | FY 2019-20 |
|---|---|---|---|---|---|
| Profit and Loss Statement | |||||
| Revenue from Operations | |||||
| Other Income | |||||
| Total Revenue | |||||
| Cost of Materials Consumed | |||||
| Employee Benefit Expense | |||||
| Finance Costs | |||||
| Depreciation and Amortisation | |||||
| Other Expenses | |||||
| Total Expenses | |||||
| EBITDA | -₹44.49 Lakh | ||||
| Profit Before Tax | |||||
| Tax Expense | |||||
| Net Profit (PAT) | -₹45.15 Lakh | ||||
| Balance Sheet | |||||
| Share Capital | |||||
| Reserves and Surplus | |||||
| Net Worth (Total Equity) | |||||
| Long-term Borrowings | |||||
| Short-term Borrowings | |||||
| Trade Payables | |||||
| Total Liabilities | |||||
| Fixed Assets | |||||
| Investments | |||||
| Inventories | |||||
| Trade Receivables | |||||
| Cash and Bank Balance | |||||
| Total Assets | |||||
Financial Ratios
| Metrics | FY 2023-24 | FY 2022-23 | FY 2021-22 | FY 2020-21 | FY 2019-20 |
|---|---|---|---|---|---|
| Profitability | |||||
| EBITDA Margin | -9.8% | ||||
| Net Profit Margin | -9.9% | ||||
| Return on Equity (ROE) | |||||
| Return on Capital Employed (ROCE) | |||||
| Return on Assets (ROA) | |||||
| Liquidity and Debt | |||||
| Current Ratio | |||||
| Quick Ratio | |||||
| Debt-to-Equity Ratio | |||||
| Interest Coverage Ratio | |||||
| Efficiency and Growth | |||||
| Asset Turnover | |||||
| Receivable Days | |||||
| Payable Days | |||||
| Inventory Days | |||||
| Revenue Growth | |||||
| Net Profit Growth | |||||
To see the full financial statements and ratios of Lanark Laboratories Pvt Ltd, buy the company report.
Board of directors of Lanark Laboratories Pvt Ltd
Lanark Laboratories has 3 current directors and 1 former director. Current directors are listed first, with their designation and appointment date.
| Name | Designation | Appointment Date | Tenure | Status |
|---|---|---|---|---|
| Anil Mehta Also directs: Zee Laboratories Limited, Antek Drugs Private Limited | Director | 11 Jun 2015 | 11 Years 5 Months | Current |
| Rajeev Mukul Also directs: Palm Land Hotel & Resorts LLP, Klokter Life Sciences Private Limited, Klokter Healthcare Private Limited and 5 more | Director | 01 Aug 2010 | 16 Years 3 Months | Current |
| Dinesh Kakar Also directs: Klokter Life Sciences Private Limited, JJ Logistics and Technopark Private Limited, Deventure Hotels Private Limited and 5 more | Director | 01 Jul 2003 | 23 Years 4 Months | Current |
Auditor
Lanark Laboratories Pvt Ltd is audited by TAGEJA R & CO for the financial year 2022.
| Auditor firm | Financial year | Firm registration number |
|---|---|---|
| TAGEJA R & CO | FY 2022 | 036385N |
Shareholding
The shareholding of Lanark Laboratories Pvt Ltd is on record for 5 financial years, the latest being FY 2022, split between promoters, domestic institutions, public shareholders and others.
| Shareholder category | FY 2022 | FY 2021 | FY 2020 | FY 2019 | FY 2018 |
|---|---|---|---|---|---|
| Promoters | |||||
| Domestic institutional investors (DII) | |||||
| Public | |||||
| Others |
To see the full shareholding pattern of Lanark Laboratories Pvt Ltd, buy the company report.
Legal cases
Lanark Laboratories Pvt Ltd has 2 court cases on record: 2 filed against it. 1 case is pending and 1 is disposed.
Cases by court
| Court | Cases | Against the company | Pending |
|---|---|---|---|
| District courts | 2 | 2 | 1 |
Cases on record (2 of 2)
| Court | Type of case | Party | Status |
|---|---|---|---|
| District court, South East, Delhi | Court case (TM) | Filed against the company by Sun Pharmaceutical Industries Limited | Disposed |
| District court, West Singhbhum at Chaibasa, Jharkhand | Court case (Drugs And Cosmetic Cases) | Filed against the company by Union of India | Pending |
To see the full case history of Lanark Laboratories Pvt Ltd, buy the company report.
Case records are compiled from court listings and may lag the court's own records. A case filed against a company is not a finding against it.
MSME payment delays
No delayed payments to MSME suppliers are on our record for Lanark Laboratories Pvt Ltd; the supplier-wise MSME Form 1 check is in the company report Buy the company report.
Employees & EPFO
Lanark Laboratories Pvt Ltd has a workforce of 18 employees on its EPFO records as of May 2026, across 1 active EPFO establishment.
Headcount by financial year
| Financial year | Employees (EPFO) |
|---|---|
| FY 2026-27 | 18 |
| FY 2025-26 | |
| FY 2024-25 | |
| FY 2023-24 | |
| FY 2022-23 | |
| FY 2021-22 | |
| FY 2020-21 | |
| FY 2019-20 | |
| FY 2018-19 | |
| FY 2017-18 | |
| FY 2016-17 |
To see the full employee and EPFO history of Lanark Laboratories Pvt Ltd, buy the company report.
GST
Lanark Laboratories has 1 GST registration: 1 active.
| GSTIN | State | Status | Registered on |
|---|---|---|---|
| 06AAACL8015D1ZY | Haryana | Active | 01 Jul 2017 |
To see the full GST registrations and return filing status of Lanark Laboratories Pvt Ltd, buy the company report.
Recent activity
Lanark Laboratories Pvt Ltd has 4 board changes on record since 2003: 3 appointments and 1 cessation. The latest: Raj Rani Mukul ceased to be Director on 02 Nov 2015.
Frequently asked questions
Lanark Laboratories is an active private limited company based in New Delhi, Delhi, India. The company works in drug formulation and development, within the pharma industry. It was incorporated on 13 May 2001 (25+ years old) and is registered under CIN U24232DL2001PTC111048.
Lanark Laboratories has 3 current directors:
- Anil Mehta - Director
- Rajeev Mukul - Director
- Dinesh Kakar - Director
The latest financial statements of Lanark Laboratories on record with the MCA are for the year ended 31 March 2024. Its last annual general meeting was held on 28 September 2024. Year-wise statements from 2015 are in the company report.
The GSTIN of Lanark Laboratories is 06AAACL8015D1ZY, registered in Haryana.
The CIN (Corporate Identification Number) of Lanark Laboratories is U24232DL2001PTC111048. It is issued by the Ministry of Corporate Affairs under the Companies Act, 2013, and uniquely identifies the company in India.
Lanark Laboratories has 2 court cases on record: 2 filed against it. 1 is pending.
Lanark Laboratories was incorporated on 13 May 2001, making it 25+ years old. It is registered with the Registrar of Companies, Delhi.
Raj Rani Mukul ceased to be Director on 02 Nov 2015. Anil Mehta was appointed as Director on 11 Jun 2015. Rajeev Mukul was appointed as Director on 01 Aug 2010. Lanark Laboratories has 4 board changes on record in total.
Lanark Laboratories can be reached through the website lanarklab.com. Its registered office is in New Delhi, Delhi, India.
The registered office of Lanark Laboratories is at 913, D – Mall Plot No. A – 1 Netaji Subhash Place Pitampura, New Delhi, Delhi, India – 110038.

